Lavipharm Cash Per Share vs. Profit Margin

LAVI Stock  EUR 0.75  0.01  1.35%   
Taking into consideration Lavipharm's profitability measurements, Lavipharm SA may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Lavipharm's ability to earn profits and add value for shareholders.
For Lavipharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lavipharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lavipharm SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lavipharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lavipharm SA over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Lavipharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lavipharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lavipharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lavipharm SA Profit Margin vs. Cash Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Lavipharm's current stock value. Our valuation model uses many indicators to compare Lavipharm value to that of its competitors to determine the firm's financial worth.
Lavipharm SA is currently regarded as number one stock in cash per share category among its peers. It also is currently regarded as number one stock in profit margin category among its peers fabricating about  0.62  of Profit Margin per Cash Per Share. The ratio of Cash Per Share to Profit Margin for Lavipharm SA is roughly  1.61 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lavipharm's earnings, one of the primary drivers of an investment's value.

Lavipharm Profit Margin vs. Cash Per Share

Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Lavipharm

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.04 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Lavipharm

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
0.02 %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.

Lavipharm Profit Margin Comparison

Lavipharm is currently under evaluation in profit margin category among its peers.

Lavipharm Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Lavipharm, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lavipharm will eventually generate negative long term returns. The profitability progress is the general direction of Lavipharm's change in net profit over the period of time. It can combine multiple indicators of Lavipharm, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Lavipharm S.A. develops, manufactures, markets, and distributes pharmaceutical, cosmetic, and consumer health products in Greece and internationally. Lavipharm S.A. was founded in 1911 and is based in Paiania, Greece. LAVIPHARM operates under Drug Manufacturers - Major classification in Greece and is traded on Athens Stock Exchange.

Lavipharm Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Lavipharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lavipharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lavipharm's important profitability drivers and their relationship over time.

Use Lavipharm in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lavipharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lavipharm will appreciate offsetting losses from the drop in the long position's value.

Lavipharm Pair Trading

Lavipharm SA Pair Trading Analysis

The ability to find closely correlated positions to Lavipharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lavipharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lavipharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lavipharm SA to buy it.
The correlation of Lavipharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lavipharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lavipharm SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lavipharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Lavipharm position

In addition to having Lavipharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling
Gambling Theme
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Lavipharm Stock Analysis

When running Lavipharm's price analysis, check to measure Lavipharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lavipharm is operating at the current time. Most of Lavipharm's value examination focuses on studying past and present price action to predict the probability of Lavipharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lavipharm's price. Additionally, you may evaluate how the addition of Lavipharm to your portfolios can decrease your overall portfolio volatility.